Ovctek China, Inc. Hits Day Low of CNY 13.91 Amid Price Pressure

Ovctek China, Inc., a large-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 5.21% on March 23, 2026. The stock reached an intraday low of CNY 13.91, reflecting ongoing challenges for the company. In terms of performance metrics, Ovctek has consistently underperformed against the China Shanghai Composite index. Over the past year, the stock has declined by 15.61%, while the benchmark has gained 13.33%. This trend of underperformance extends over multiple time frames, with a staggering 57.37% drop over the last three years and a significant 75.18% decrease over the past five years. Financial indicators reveal that the company has reported negative results for the last four consecutive quarters. Key metrics include an operating cash flow of CNY 795.84 million, the lowest recorded, and a return on capital employed (ROCE) of just 10.24%. With a market capitalization of CNY 10,271 million, Ovctek's current P/E ratio stands at 27.00, while its dividend yield is at 2.44%.